Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
39.14
+1.42 (3.76%)
At close: Jan 22, 2026, 4:00 PM EST
39.14
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:20 PM EST
Vericel Market Cap
Vericel has a market cap or net worth of $1.98 billion as of January 22, 2026. Its market cap has decreased by -30.25% in one year.
Market Cap
1.98B
Enterprise Value
1.93B
1-Year Change
-30.25%
Ranking
Category
Stock Price
$39.14
Market Cap Chart
Since December 1, 1998, Vericel's market cap has increased from $31.90M to $1.98B, an increase of 6,105.23%. That is a compound annual growth rate of 16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.91B | 4.75% |
| Dec 31, 2025 | 1.82B | -32.80% |
| Dec 31, 2024 | 2.71B | 59.48% |
| Dec 29, 2023 | 1.70B | 36.63% |
| Dec 30, 2022 | 1.24B | -32.39% |
| Dec 31, 2021 | 1.84B | 31.15% |
| Dec 31, 2020 | 1.40B | 80.38% |
| Dec 31, 2019 | 777.70M | 3.12% |
| Dec 31, 2018 | 754.20M | 296.53% |
| Dec 29, 2017 | 190.20M | 163.07% |
| Dec 30, 2016 | 72.30M | 17.75% |
| Dec 31, 2015 | 61.40M | -15.08% |
| Dec 31, 2014 | 72.30M | 412.77% |
| Dec 31, 2013 | 14.10M | -74.46% |
| Dec 31, 2012 | 55.20M | -21.48% |
| Dec 30, 2011 | 70.30M | -2.77% |
| Dec 31, 2010 | 72.30M | 35.14% |
| Dec 31, 2009 | 53.50M | -20.74% |
| Dec 31, 2008 | 67.50M | -2.17% |
| Dec 31, 2007 | 69.00M | -53.19% |
| Dec 29, 2006 | 147.40M | -32.17% |
| Dec 30, 2005 | 217.30M | 65.88% |
| Dec 31, 2004 | 131.00M | 38.19% |
| Dec 31, 2003 | 94.80M | 321.33% |
| Dec 31, 2002 | 22.50M | -45.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 2.06B |
| Aurinia Pharmaceuticals | 1.95B |
| Ardelyx | 1.94B |
| Nurix Therapeutics | 1.93B |
| Monte Rosa Therapeutics | 1.92B |
| MBX Biosciences | 1.85B |
| Sionna Therapeutics | 1.82B |
| Zymeworks | 1.79B |